Results of a pre-clinical study of an experimental nootropic drug called Gilatide have shown that it is capable of boosting memory in a number of different animals. Using microarray technology, the researchers also found the drug leads to changes in gene expression that encourage learning and memory.
Results of a pre-clinical study of an experimental nootropic drug called Gilatide have shown that it is capable of boosting memory in a number of different animals. Using microarray technology, the researchers also found the drug leads to changes in gene expression that encourage learning and memory. Dr Colin Haile, an assistant professor at Thomas Jefferson Medical College where the research was conducted, said that Gilatide was “an exciting development for the treatment of human memory disorders.’ It is thought that the drug will benefit people suffering from mild cognitive impairment and age-related memory loss.
SOURCE/REFERENCE: Reported by www.bioexchange.com on the 13th November 2001
